New hope for Meniere's sufferers: drug trial targets dizziness and hearing issues
Disease control
Recruiting now
This study tests a drug called SPI-1005 in 200 adults with Meniere's disease, a condition causing dizziness, hearing loss, and ear fullness. Participants take the drug twice daily for 6 or 12 months to see if it is safe and helps control symptoms. The goal is to support long-term…
Phase: PHASE3 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Disease control
Last updated May 18, 2026 02:05 UTC